Tissue angiotensin 2--potential advantage in the therapeutic approach to the treatment of hypertension
Zimlichman, E.; Zimlichman, R.
Harefuah 132(2): 113-116
1997
ISSN/ISBN: 0017-7768 PMID: 9119293 Document Number: 483744
Document emailed within 1 workday
Related Documents
Dabrowski, R.ł; Szwed, H. 2007: Atrial fibrillation: potential therapeutic interventions in the renin-angiotensin-aldosterone system Kardiologia Polska 65(4): 440-445Horiuchi, M. 2016: The Protective Arm of Renin Angiotensin System; Recent Research Progress and Expectation for new Therapeutic Approach Nihon Rinsho. Japanese Journal of Clinical Medicine 74(9): 1583-1589
Ripka, O.; Ort, J.; Linhartová, J.; Tvrzická, E.; Reinisová, J. 1972: Renin-angiotensin system in the diagnosis of renovascular hypertension. Radioimmunoassay of angiotensin i and angiotensin Ii Casopis Lekaru Ceskych 111(35): 818-820
SenGupta, A.; Kevau, I.H. 1993: A therapeutic approach to hypertension Papua and new Guinea Medical Journal 36(1): 63-70
Abassi, Z.; Armaly, Z.; Nakhoul, F.; Hoffman, A. 2008: Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension Harefuah 147(6): 536
Accardo, G. 1982: New therapeutic approach to arterial hypertension using acebutolol Giornale di Clinica Medica 63(5): 330-336
Wirth, A. 2003: Losing weight as a countermeasure to diabetes, hypertension, stroke... the therapeutic potential is enormous MMW Fortschritte der Medizin 145(42): 29
Ab Hamid, J.; Mohtarrudin, N.; Osman, M.; Andi Asri, A.A.; Wan Hassan, W.H.; Aziz, R. 2012: Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 and 2 as potential biomarkers for gestational hypertension Singapore Medical Journal 53(10): 681-683
Soldner, A.; Spahn-Langguth, H.; Mutschler, E. 1996: The renin-angiotensin-aldosterone system: focus on its distinct role in arterial hypertension and its various inhibitors as a therapeutic strategy to effectively lower blood pressure Die Pharmazie 51(11): 783-799
Kotyla, P.ła.J. 2014: Pleiotropic activity of 3-hydroxy-3-methyl-glutharyl-coenzyme a inhibitors (statins). therapeutic potential in connective tissue diseases Annales Academiae Medicae Stetinensis 60(1): 39-45; Discussion: 45-46
Ménard, J. 1993: Anthology of the renin-angiotensin system: a one hundred reference approach to angiotensin II antagonists Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 11(3): S3-11
Gerc, V. 2002: Role of angiotensin Ii antagonists in the treatment of hypertension Medicinski Arhiv 56(3): 167-173
Ganten, D.; Mullins, J.; Lindpaintner, K. 1989: The tissue renin-angiotensin system: a target for angiotensin-converting enzyme inhibitors Journal of Human Hypertension 3(Suppl 1): 63-70
Murad, C.S. 1992: Ambulatory blood pressure monitoring. A new approach in the diagnosis and therapeutic management of arterial hypertension Arquivos Brasileiros de Cardiologia 59(6): 475-482
Falch, D. 1983: Saralasin in the diagnosis of angiotensin-dependent hypertension and in the study of the renin-angiotensin-aldosterone system Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 103(11): 906-908
Mancia, G. 1991: Angiotensin-converting enzyme inhibitors in the treatment of hypertension Journal of Cardiovascular Pharmacology 18(Suppl 7): S1-S3
Ol'binskaia, L.I.; Morozov, I.A. 1996: Angiotensin-Ii receptor blockers in the treatment of arterial hypertension Eksperimental'naia i Klinicheskaia Farmakologiia 59(5): 76-80
Coats, A.J. 1987: Angiotensin-converting-enzyme inhibitors in the treatment of hypertension British Journal of Hospital Medicine 38(6): 531
Materson, B.J. 1983: Angiotensin converting enzyme inhibitors in the treatment of hypertension Comprehensive Therapy 9(10): 14-20
Babadzhan, V.D. 2000: Angiotensin-converting enzyme inhibitors in the treatment of arterial hypertension Likars'ka Sprava 2: 19-26